Optometry Virtually Connected 2023
Provider: OA National Provider
Contact: Optometry Australia OA Provider, [E] cpd@optometry.org.au, [P] 96688550
Registration: https://ovc.joyn-us.app/registration/new
Learning Objectives
- Develop an understanding of the difference between machine learning and deep learning
- Develop an understanding of the difference between AI and statistical analysis
- Develop an appreciation of the range of factors limiting AI deployment in eye care
- Understand how ocular surface diseases can arise from, and be exacerbated by, common lifestyle choices such as diet and cosmetics
- Understand the role local indoor and external environmental exposures play in driving the development of ocular surface diseases
- Gain knowledge to help patients optimise quality of life using evidence-based recommendations, to minimise impacts of lifestyle choices and mitigate ocular surface disease development and propagation
- Review the cycle of inflammation associated with the ‘vicious circle of dry eye disease’
- Appreciate diagnostic criteria for dry eye disease categorisation
- Consider current topical and oral therapeutic management strategies that best combat the clinical signs observed
- Review the pathophysiology of blepharitis and DED
- Understand effective management strategies for DED and co-morbidities
- Consider the correlation between effective treatment strategies and patient satisfaction and quality of life
- Explain how climate variables and environmental conditions can affect ocular surface health and function
- Apply consensus-based guidelines to protect the ocular surface during extreme climate events
- Proactively manage populations which are at greater risk of ocular surface disease during extreme climate events
- Review the features of the most complete daily disposable silicone hydrogel lens on the market and its benefits for patients
- Understand the technology of Alcon’s PRECISION BALANCE 8|4 toric lens design
- Identify patients with severe keratitis from dry eye disease
- Choose the most appropriate treatment option for individual patients
- Recall the key outcomes from the real-world PERSPECTIVE study
- Describe the correct use of Ikervis in eligible patients, including the prescribing process
- Gain a comprehensive overview of the myopia control treatments available in Australia, and how to pick the right treatment for your patient
- Learn the expected efficacy of each treatment, how to gauge your patient’s treatment effect, and to identify when a patient might need to consider dual therapy
- Explain the role of near work in myopia
- Understand how the biometry changes during near work
- Understand the varying opinions on binocular vision and accommodation errors in myopia
- Understand how the relative peripheral spherical equivalent refraction nasally and temporally may impact upon the development of myopia
- Understand how anatomical asymmetry in the retina in the nasal and temporal regions in terms of cone and ganglion cell density may impact upon the development of myopia
- Assess and recognise signs of pathological myopia
- Become familiar with the primary components in early ocular growth, the impact of such growth on refractive development as well as important clinical implications
- Understand how integrated software systems can increase diagnostic confidence and clinical efficiency
- Understand how integrated software systems can assist in patient education and understanding of their disease
- Understand how Integrated software systems can promote collaborative care and support effective communication between professionals
- Understand the responsibility of optometrists to deliver culturally safe practice
- Identify key features of evidence-based models of eye care
- Understand the technology and benefits of the Ultra Monthly lens family and how they will benefit patients to live better and see better
- Describe the advances in contact lens technology, including drug delivery and smart lenses
- Understand how contact lenses affect the binocular vision system
- Appreciate the impact of different contact lens designs on the binocular vision system
- Understand the benefits of ACUVUE Eye Inspired Innovations and how they link to patient experience and retention
- Understand how tools like MyACUVUE can help optometry practices retain patients
- Consider the levers that relate to patient retention in the contact lens category
- Understand the visual optics and prescribing patterns necessary for successful prescribing of contact lenses for presbyopia
- Recognise the modifiable and non modifiable risk factors for contact lens associated corneal infection
- Design strategies for communicating healthy contact lens wear
- Develop an understanding of how MiSight 1 day slowed the myopia of children progressing at different rates
- Develop an understanding of how different measures can be used to fully understand treatment efficacy in myopia management
- Identify the main types of systemic anticancer drugs used in medical oncology settings (chemotherapy, hormonal agents, targeted therapies)
- Recognise ocular complications arising from treatment with anticancer drugs, and the appropriate management for these side effects
- Better understand the role obesity plays in a range of eye disease
- Consider proposed modifications to examination and management protocols to incorporate known ocular complications associated with obesity
- Better understand how to utilise incidence and prevalence values in clinical practice
- Develop confidence in assessing myopic patients prior to potential cataract surgery
- Understand appropriate refractive targets, surgical methods and intraocular lens choices for myopic patients based on individual patient characteristics
- Recognise the relationship between myopia and glaucoma
- Understand the diagnostic challenges faced when both coexist
- Discuss the new tools to aid in the diagnosis and management
- Describe the impacts of the most important systemic autoimmune cause of blindness
- Describe the impacts of the most important systemic autoinflammatory causes of blindness
- Recognise when eye inflammation is autoimmune versus autoinflammatory versus infective
- Understand when to initiate and maintain management or refer appropriately
- Understand when to use which steroids and when to avoid them
- Understand and manage microbes - to kill, control or nurture
- Understand why the optometrist has an important role in routine care for people living with dementia and/or Parkinson’s Disease
- Understand how dementia and Parkinson’s Disease can impact ocular motility and binocular function, and what to look for during the routine eye examination
- Understand the relationship between cognitive impairment associated with dementia, eye care access inequities and poor visual outcomes
- Learn ways to modify management of common age-related eye diseases to accommodate cognitive impairment
- Understand the tips and tricks to better counsel and manage patients with trifocal IOLs pre- and post-operatively in order to improve patient outcomes and satisfaction
Max CPD hours awarded: UP TO 22 (12T)
Session Information
Name |
---|
Opening Keynote Address: AI, data and eye care |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
Eyes on our lifestyle: the impact of our daily habits on ocular surface health |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Don’t leave your patients high and dry! Targeted topical and oral therapeutics for dry eye disease |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Zap, squeeze, scrub, scrape and drape! Effective management strategies for dry eye disease |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
How will climate change affect the ocular surface? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Ultra® One Day – Go Beyond with the Most Complete |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Astigmats and the Upgrade Conundrum |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
The PERSPECTIVE real-world study: Insights for the Australian setting |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Staying in control of progressing myopia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Near work and myopia: The divergent opinions regarding binocular vision and accommodation errors in myopia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Review of Myopia Control with Rodenstock |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
When they slip through the cracks: assessment and management of pathological myopia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Magic growth curves to predict myopia development, are we there yet? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
The Benefits of Integrated Imaging Software in Optometry Practice |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Plenary Session: CXO Presents: Public health and Indigenous eye health: Optometry needs to do more |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Ultra® Monthlies – Comfort, Vision & Eye Health |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
As far as the eye can see - new contact lens technologies |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
The effects of contact lenses on the binocular vision system |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Maximizing patient retention in optometry practices: Leveraging product and business model innovation |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
An arm’s length look at contact lens options for presbyopia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
C is for Compliance, but A is for Adherence: Helping contact lens wearers score an A |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
What we’ve learned and what questions remain after the 7-year MiSight® 1 day clinical trial |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Beyond chemo-fog: Ocular complications from anticancer drugs |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Obesity and eye disease: What weight should it place on your clinical examination? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Cataract surgery in myopes - management tips and pitfalls for optometrists & Glaucoma and Myopia – Challenges in diagnosis and management |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Systemic autoimmune disease and eye health. Not quite what you expected? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Looking after the eyes to look after the brain: Neurodegenerative diseases and eye health |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |
Name |
---|
Optometrists & trifocal IOLs – Improving outcomes through collaboration |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |